Navigation Links
Neurocrine Biosciences Reports Third Quarter 2008 Results
Date:10/28/2008

September 30,

2008 2007 2008 2007

(unaudited) (unaudited)

Revenues:

Sponsored research and

development $32 $13 $48 $120

License fees and milestones 729 500 3,189 500

Grant Revenue - 27 9 72

Total revenues 761 540 3,246 692

Operating expenses:

Research and development 12,993 19,795 43,406 57,645

Sales, general and

administrative 3,472 9,571 16,423 26,695

Total operating expenses 16,465 29,366 59,829 84,340

Loss from operations (15,704) (28,826) (56,583) (83,648)

Other income and (expenses):

Interest income and expense,

net (93) 2,413 2,573 6,869

Other income and (expense),

net (1,914) (827) (5,749) (2,545)

Total other income (2,007) 1,586 (3,176) 4,324

Net loss $(17,711) $(27,240) $(59,759) $(79,324)

Net loss per common share:

Basic and diluted $(0.46) $(0.72) $(1.56) $(2.09)

Shares used in the calculation

of net loss per common share:

Basic and diluted 38,446 37,990 38,399 37,956

NEUROCRINE BIOSCIENCES, INC.

Condensed Consolidated Statements of Operations

(in thousands, except for per share data)

September December

30, 31,


'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Webcast Alert: Neurocrine Announces 3Q 08 Financial Results
2. Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2008 Financial Results
4. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
5. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
6. Neurocrine Biosciences Reports Second Quarter 2008 Results
7. Neurocrine Biosciences Announces Conference Call and Webcast To Present Second Quarter 2008 Financial Results
8. Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
11. Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... GMO corn cases filed across the United ... process of being consolidated in a Kansas federal court for ... MIR 162 Corn Litigation, MDL No. 2591 in the U.S. ... the Syngenta GMO corn multidistrict litigation (MDL) has been handed ...
(Date:12/24/2014)... December 23, 2014 SoundConnect’s ... to introduce cutting edge communication technology, provide continued ... upgrades. This webinar series demonstrates online communication features ... leverage web conferencing’s most innovative and powerful tools. ...
(Date:12/24/2014)... December 23, 2014 According to Ross Selinger, ... Affiliate of ITRA Global, the national office market continues to ... This is evidenced by the third quarter’s surprising 3.9% ... Low energy costs have held inflation down and the ...
(Date:12/24/2014)... Tenn. (PRWEB) December 23, 2014 Nashville Fertility ... elected treasurer for the American Society for Reproductive Medicine (ASRM), ... in reproductive medicine. In his new role as treasurer, ... and will have a voice in furthering the mission of ...
Breaking Biology Technology:Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3
... ANN ARBOR, Mich.---By digitally photographing the tiny, hair-like blood ... look directly at how small blood vessels like those that ... New digital photos of the retina revealed that otherwise healthy ... retinal arterioles, an indication of a higher risk of heart ...
... In 2008, experiments at The Fu Foundation School ... pure graphene, a single layer of graphite only one ... This raised a question for Chris Marianetti, Assistant Professor ... Mathematics: how and why does graphene break? ...
... succeeded in creating artificial spin ice in a state ... to examine the precise configuration of this important nanomaterial. ... Department of Energy,s Brookhaven National Laboratory and the UK ... the breakthrough will allow them to study in much ...
Cached Biology Technology:Photos of tiny blood vessels in the eye link air pollution to heart disease 2Columbia engineering team discovers graphene's weakness 2Scientists create highly ordered artificial spin ice using nanotechnology 2Scientists create highly ordered artificial spin ice using nanotechnology 3
(Date:12/17/2014)...  HITLAB SM announced today its completion of a ... to current U.S. Food and Drug Administration (FDA) regulations. ... and smart phone application trials utilizing the highest principles ... is determined to improve global healthcare access, quality, and ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of ...  report to their offering. One major ... With continuous advances in technology, it is important to ...
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader in performance ... a staggering demand from its licensees for highly accurate, ... is not solely coming from fitness and health sectors, ... "A wearable is only as useful as the ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... Researchers at the University of Illinois have designed a small ... type 1, the most common form of muscular dystrophy. ... tightly to its target, an abnormally elongated RNA that hijacks ... of the disease. The newly developed compound is the first ...
... neutralizing toxins produced by blue-green algae have been ... Aakash Welgama presented the group,s findings during the ... Edinburgh. Blooms of blue green algae (cyanobacteria) ... throughout the world. They produce toxins called microcystins ...
... people with type 2 diabetes that affects how the ... a new study published today in Nature Genetics ... international institutions, say the findings highlight a new target ... have identified several genetic variations in people with type ...
Cached Biology News:Small molecule inhibits pathology associated with myotonic dystrophy type 1 2Scientists discover new genetic variation that contributes to diabetes 2
... Slide Table is designed for moving loads ... provides maximum force output while limiting overall ... of stainless steel ball bearings guided on ... self-compensating shock absorbers provide energy absorption and ...
... P5T Series Short Stroke Thrust Slide is ... where mounting envelopes are limited and substantial ... and internal bumpers provide millions of trouble-free ... Choice of composite bushings or recirculating ball ...
Hamster Serum; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin levels; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin levels....
Alkaline Phosphatase (E. coli C75), 100 units. Removes 5'-phosphates from DNA. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Alkaline Phosphatases....
Biology Products: